Works matching IS 09509232 AND DT 2012 AND VI 31 AND IP 15
Results: 10
Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1896, doi. 10.1038/onc.2011.378
- By:
- Publication type:
- Article
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1884, doi. 10.1038/onc.2011.380
- By:
- Publication type:
- Article
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1988, doi. 10.1038/onc.2011.387
- By:
- Publication type:
- Article
Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1938, doi. 10.1038/onc.2011.377
- By:
- Publication type:
- Article
Stabilization of phenotypic plasticity through mesenchymal-specific DNA hypermethylation in cancer cells.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1963, doi. 10.1038/onc.2011.373
- By:
- Publication type:
- Article
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1910, doi. 10.1038/onc.2011.381
- By:
- Publication type:
- Article
Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1923, doi. 10.1038/onc.2011.379
- By:
- Publication type:
- Article
Regulation of APC/C<sup>Cdc20</sup> activity by RASSF1A-APC/C<sup>Cdc20</sup> circuitry.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1975, doi. 10.1038/onc.2011.372
- By:
- Publication type:
- Article
Molecular mechanisms of cisplatin resistance.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1869, doi. 10.1038/onc.2011.384
- By:
- Publication type:
- Article
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.
- Published in:
- Oncogene, 2012, v. 31, n. 15, p. 1949, doi. 10.1038/onc.2011.394
- By:
- Publication type:
- Article